Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06471504 · ClinicalTrials.gov registry record · NA

Use of Eye Tracking to Aid in Autism Risk Detection

A NA study of Autism, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06471504 is a NA study of Autism that is actively recruiting participants, run by Indiana University. The registered enrollment target is 100 participants, below the 182-participant average among 104 other Autism trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06471504, a NA study of Autism, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Eyelink Portable Duo

Study Locations (1)

Indiana

  • Riley Hospital for Children - Indianapolis

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-01-08
Est. Completion 2026-04-30
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT06471504

The ClinicalTrials.gov registry entry for NCT06471504 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 182-participant average among 104 other Autism trials with a reported enrollment target (45% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Eyelink Portable Duo is the first listed.

NCT06471504 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT06471504 about?

NCT06471504 is a clinical study titled "Use of Eye Tracking to Aid in Autism Risk Detection". The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures.

What is the current status of trial NCT06471504?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-01-08. Estimated completion is 2026-04-30.

What conditions does trial NCT06471504 study?

This clinical trial studies the following conditions: Autism.

What interventions are being tested in trial NCT06471504?

The interventions under investigation include: Eyelink Portable Duo (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06471504?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06471504 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.